| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |